Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5215)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 27, 2021 (publication date) through Dec 9, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gastaca M, Ruiz P, Bustamante J, Martinez-Indart L, Ventoso A, Fernandez JR, Palomares I, Prieto M, Testillano M, Salvador P, Senosiain M, Suárez MJ, Valdivieso A. Early tacrolimus exposure does not impact long-term outcomes after liver transplantation. World J Hepatol 2021; 13(3): 362-374 [PMID: 33815678 DOI: 10.4254/wjh.v13.i3.362] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v13/i3/362.htm |
| Number | Citing Articles |
| 1 |
Faiza Ahmed, Faiza Zakaria, Godsgift Enebong Nya, Mohamad Mouchli. Sirolimus <i>vs</i> tacrolimus: Which one is the best therapeutic option for patients undergoing liver transplantation for hepatocellular carcinoma?. World Journal of Gastrointestinal Surgery 2022; 14(8): 862-866 doi: 10.4240/wjgs.v14.i8.862
Abstract(236) |
Core Tip(194) |
Full Article(HTML)(754)
|
Full Article (PDF)-1760K(104)
|
Full Article (Word)-109K(66)
|
Peer-Review Report-460K(26)
|
Answering Reviewers-101K(34)
|
Times Cited (0)
|
Total Visits (2383)
|
Open
|
| 2 |
Alexandre Destere, Aurélie Premaud, Caroline Monchaud, Pierre Marquet, Jean-Baptiste Woillard. Longitudinal Exposure to Tacrolimus and New-Onset Diabetes Mellitus in Renal Transplant Patients. Therapeutic Drug Monitoring 2023; 45(1): 102 doi: 10.1097/FTD.0000000000001035
|